
Breaking news from across the pharma sector

30 April 2026 -- Silverstone, UK -- Lab Thread Ltd, a UK-based life science software company, today announced the worldwide commercial release of its Unified Lab Software Platform.

23 April 2026 -- Essen, Germany -- Brenntag, the global market leader in chemicals and ingredients distribution, unveiled BYPHAR yesterday in an online live press event.

22 April 2026 -- Birmingham, UK -- Impli, a pioneering health technology company developing implantable biosensors for real-time hormone monitoring, has become the first commercial lab resident at Birmingham’s PHTA, targeting team growth, human trials and manufacturing readiness.

22 April 2026 -- Loughborough, UK -- Myomaker Bio, a spin-out from Loughborough University, is scaling its technology to support pharmaceutical and biotech companies in developing new treatments faster, more accurately and without the need for testing on animals.

21 April 2026 -- Glasgow, UK -- CMAC, led by the University of Strathclyde, the UK’s foremost academic research centre for pharmaceutical manufacturing and digital CMC, can now draw on a decade of accumulated manufacturing knowledge. This will accelerate the development of new medicines and processes, connecting data across multiple interconnected systems that were previously impossible to interrogate together.

21 April 2026 -- Hannover, Germany -- Dassault Systèmes and OMRON, a global leader in industrial automation technologies, today announced their partnership to bridge the gap between information technology (IT) and operational technology (OT). This collaboration enables manufacturers and machine builders to design, simulate, and deploy smarter, more flexible, and higher-performing production systems through a unified approach that merges virtual and real environments.

20 April 2026 -- Irving, Texas -- iProcess Global Research Inc. today announced the launch of AxisOne (axisone.ai), an AI-powered platform the company calls the R&D operating system for the world.

17 April 2026 -- Munich, Germany -- At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division announces the European launch of MyGenius PRO, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology.

14 April 2026 -- California, US -- Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced that Cabaletta Bio Inc.’s investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) has been infused into the first two patients using drug product manufactured on Cellares’ Cell Shuttle automated manufacturing platform.

14 April 2026 -- Bagsværd, Denmark -- Novo Nordisk today announced a strategic partnership with OpenAI that will place Novo Nordisk at the forefront of AI transformation in healthcare and help the company bring new and better treatment options to patients faster.

13 April 2026 -- California, US -- At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and automation across research and applied NMR.

8 April 2026 -- Ohio, US -- CAS, a division of the American Chemical Society, today announced the launch of CAS NewtonSM, science-smart agentic AI built specifically for scientific discovery. CAS Newton is grounded in published scientific knowledge curated by CAS scientists, drawing on more than 150 years of literature within the CAS Content CollectionTM to ensure accuracy and scientific rigor.